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E-Cadherin/β-catenin complex plays an important role in maintaining epithelial integrity and disrupting this complex aﬀect not
only the adhesive repertoire of a cell, but also the Wnt-signaling pathway. Aberrant expression of the complex is associated with a
wide variety of human malignancies and disorders of ﬁbrosis resulting from epithelial-mesenchymal transition. These associations
provide insights into the complexity that is likely responsible for the ﬁbrosis/tumor suppressive action of E-cadherin/β-catenin.
1.Introduction
Cell-cell junctions are important to maintain cell and tissue
polarity and integrity. In general, vertebrate animals possess
three intercellular junction systems: gap junctions, which
serve as intercellular channels that permit direct cell-cell
transfer of ions and small molecules; tight junctions, the
primary cellular determinant of epithelial barrier func-
tion; anchoring junctions, which includes desmosomes and
adheren junctions (AJs) that associate with the cortical
cytoskeleton to mediate cell and tissue behavior [1]. Among
constituent structural molecules that assemble to form AJ,
cadherin/catenin-based anchoring junctions organize and
tether microﬁlaments to maintain cell adhesive properties
and integrate intra- and intercellular signaling, including
regulation of nuclear functions and transcription pathways
[2, 3]. This paper focuses on the role of E-cadherin/β-
catenin protein complexes in forming the epithelial barrier
and discusses the eﬀects of dysregulating the assembly of the
E-cadherin/β-catenin adhesion complex in ﬁbrotic diseases
and cancer.
2. The Cadherin/CateninComplex
Cadherins constitute a large family of cell surface pro-
teins, including E (epithelial)-, N (neural)-, VE (vascular-
endothelial)-, P (placental)-, R (retinal)-, and K (kidney)-
cadherins [4]. Classical cadherins are single-pass trans-
membrane proteins which participate in Ca2+-dependent
cell adhesion that is necessary to form solid tissues [2,
5]. E-cadherin is functionally linked to the generation of
a polarized epithelial phenotype [6, 7]. The extracellular
region of E-cadherin extends from the cell surface and
bind to cadherins present on adjacent cells [8] whereas its
intracellular region contains binding sites to interact with
catenins and other regulatory proteins (Figure 1)[ 9]. Im-
munoprecipitation of detergent-solubilised cell extracts with
anticadherin antibodies identiﬁed major proteins involved
in the formation of cadherin: p120-, α-, β-, and γ-catenin
(plakoglobin) [10, 11]. P120 catenin acts to bind to the
juxtamembrane portion, and β-catenin or plakoglobin binds
to the carboxy-terminal 100 amino acids of the cadherin
cytoplasmic region [12]. α-catenin links β-catenin to actin,
whichinturnhastheabilitytopromoteAJproteinclustering
and stabilization of cell adhesion [13]. To allow for a
continuous assembly of cadherin/catenin complexes in AJs,
cadherins can be constitutively endocytosed and recycled
to the cell surface [14, 15]. In Drosophila epithelial cells,
exocyst components Sec5, Sec6, and Sec15 directly regulate
the traﬃcking of E-cadherin to AJs via interactions with
β-catenin [16]. Images from time-lapse microscopy using2 Journal of Biomedicine and Biotechnology
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Figure 1: E-cadherin/β-catenin complex in epithelial cell-cell adhesion and Wnt signalling.
photoactivatable-GFP-tagged β-catenin in A431 cells show
that β-catenin, internalised with E-cadherin, accumulates
at the perinuclear endocytic recycling compartment (ERC)
upon AJ dissociation [17].
3. E-Cadherin/β-Catenin-Mediated
SignalingPathways
Otherthantheirstructuralroleinstabilizingcell-cellcontact,
components of cadherin-catenin complex serve a role in
activating several key signal transduction networks. β-
catenin is a key regulator in the canonical Wnt signaling,
where cytoplasmic β-catenin translocates to the nucleus and
functions as an activator for T-cell factor (TCF)/lymphoid
enhancer factor (LEF) transcription factors that result in a
subset of cellular eﬀects involving cellular adhesion, tissue
morphogenesis, and tumor development (Figure 1)[ 18, 19].
In the absence of Wnt signals, a multiprotein destruction
complex including axin and the adenomatous polyposis
coli (APC) facilitates phosphorylation of serine residues
in the N terminus of cytosolic β-catenin, which leads to
its ubiquitination and proteosomal destruction (Figure 1)
[20]. Wnt signaling inhibits this degradative process by
binding to Frizzled receptors and signaling through the
associated low-density lipoprotein-related proteins, LRP5/6,
thereby allowing β-catenin to accumulate in the cytosol and
enter the nucleus (Figure 1)[ 21–23]. Dissociation of AJ can
inﬂuence E-cadherin endocytosis, β-catenin levels in the
ERC, and β-catenin substrate levels available downstream
for the Wnt pathway. One potential determinant in the
structural integrity of the cadherin/β-catenin complex may
lie in its phosphorylation status. Phosphorylation of E-
cadherin or β-catenin by Ser/Thr kinase CK II stabilizes the
complex [24, 25]. However, tyrosine 654 phosphorylation of
β-catenin by an intracellular signaling event disrupts the E-
cadherin/β-catenin complex and cell adhesion [26, 27]. The
phosphorylationofβ-cateninattyrosine489or142strength-
ens Wnt signaling [28, 29]. Tyrosine phosphorylation can
releaseβ-cateninfromE-cadherin,decreasecell-celljunction
adhesion, and increase cell migration and invasiveness [30].
4. E-Cadherin/β-Cateninand
Epithelial-Mesenchymal Transition(EMT)
E-cadherin/β-cateninproteincomplexesareinvolvedactively
in epithelial to mesenchymal (EMT) and mesenchymal
to epithelial (MET) transitions, which play a particularly
important role in embryo development, tissue ﬁbrosis, andJournal of Biomedicine and Biotechnology 3
cancer progression. The process of EMT is characterized
by diﬀerentiated epithelial cells that undergo a phenotypic
conversionthatgives rise to the matrix-producing ﬁbroblasts
andmyoﬁbroblasts.Epithelialcellslosetheirmarkerproteins
such as E-cadherin, zonula occludens-1 (ZO-1), and cytok-
eratin, and gain of a mesenchymal phenotype with expres-
sion of mesenchymal proteins including vimentin, α-smooth
muscle actin (α-SMA), and ﬁbroblast-speciﬁc protein-1
(FSP1), and production of interstitial matrix components
type I collagen and ﬁbronectin [31, 32]. Cell contacts are
critical determinants of EMT. Loss of E-cadherin likely
promotes β-catenin release and facilitates EMT, whereas
the expression of E-cadherin can reverse the transformed
phenotype [33–36]. β-catenin plays an important role in the
TGF-β1- and cell contact-dependent, synergistic induction
of EMT [37]. In the absence of TGF-β1, both E-cadherin and
β-catenin are rapidly degraded following contact disassem-
bly. However, TGF-β1 induces β-catenin dissociation from
epithelial contacts and stabilizes β-catenin in the cytoplasm,
making it available for nuclear import [38, 39]. So the loss
of cell-cell adhesion triggers EMT and is associated with
diseases involving EMT.
5. TheRoleofE-Cadherin/β-CatenininFibrosis
Fibrosis is an active extracellular matrix (ECM) biosynthetic
process and represents the ﬁnal pathway of chronic failure of
many organs. Evidence of EMT has been reported in kidney,
lung, liver, eye, and serosal membranes suggesting that EMT
can be closely associated with the pathogenesis of ﬁbrotic
disorders in those organs [40]. E-cadherin downregulation
responsible for the loss of cell-cell adhesion and β-catenin
upregulation for the subsequent transcriptome program of
EMT are two important changes in the process of ﬁbrosis.
Iwano et al. found that 36% of renal ﬁbroblasts, the main
eﬀector cells in kidney ﬁbrosis responsible for ECM produc-
tion, originate from renal tubular epithelial cells via EMT
[41] despite conﬂicting evidence about the relative impor-
tance of various sources of myoﬁbroblasts was reported [42].
Decreased expression of E-cadherin and early expression
of EMT-related markers as well as β-catenin cytoplasmic
translocation have been detected in kidney specimens from
patients with glomerulonephritis and diabetic and chronic
allograft nephropathies [43–46]. Similar changes appear in
lung epithelial cells of patients with idiopathic pulmonary
ﬁbrosis and usual interstitial pneumonia [47, 48], and
in biliary epithelial cells of patients with primary biliary
cirrhosis, primary sclerosing cholangitis and alcoholic liver
disease [49]. The transition of retinal pigment epithelial cells
into myoﬁbroblasts is observed in patients with proliferative
vitreoretinopathy, and peritoneal mesothelial cells from ﬂuid
eﬄuents of dialyzed patients show a mesenchymal pheno-
type with reduced E-cadherin expression [50–52]. Nuclear
β-catenin immunoreactivity suggests aberrant activation
of Wnt/β-catenin signaling and subsequent EMT in the
pathogenesis of a number of ﬁbrotic disorders. In addition
to the nuclear translocation of β-catenin, we previously
reported that matrix metalloproteinase (MMP)-mediated E-
cadherin disruption led directly to tubular epithelial cell
EMT via Slug and that MMP-9 secreted by macrophages is
capable of initiating tubular cell EMT by disruption of the
E-cadherin/β-catenin complex [45, 53].
6. The Role of E-Cadherin/β-Cateninin Cancer
EMTisanimportantmechanismforthecancerdevelopment
and initial step of metastasis [54, 55]. Disruption of E-
cadherin/β-catenin might contribute to tumor aberrant
morphogenetic eﬀects. Loss of E-cadherin expression or loss
of its normal localization at cell-cell contacts is consistently
observed at sites of EMT during tumor progression. E-
cadherin expression level is often inversely correlated with
the tumor malignancy [56–58]. Cases of invasive lobular
carcinoma have been associated commonly with the loss of
E-cadherin expression as a result of E-cadherin gene mu-
tation and promoter hypermethylation [59, 60]. Evidence
from animal models has shown that conditional deletion
of E-cadherin in p53-deﬁcient mouse mammary epithelium
promoted tumor initiation and progression to invasion and
metastasis [61]. β-catenin is a critical element in the canon-
ical Wnt signaling of tumorigenesis. Activating mutations of
β-catenin or inactivating mutations of APC or Axin have
been found to be associated with a wide variety of human
malignancies, such as colorectal, ovarian endometrial, hep-
tocellular, desmoid and pancreatic tumors [62, 63]. Cancer
studies suggest that deregulated β-catenin signaling pro-
motes tumorigenesis by inducing expression of oncogenes
suchasc-myc andcyclinD1 [64–66].Stabilizingmutationsin
the β-catenin N-terminal sequence have been found in 25%
of metaplastic breast cancers [67]. Increased cytoplasmic
and nuclear β-catenin levels have been observed in 40% of
primary breast cancers and correlated with poor prognosis
and worse patient survival [68–73].
7. Concluding Remarks
Taken together, these data show that in addition to their
adhesive functions, the E-cadherin/β-catenin complex also
plays a crucial role in modulating Wnt signaling. E-cadher-
in/β-catenin complex maintains integrity of epithelial cell-
cell contact and keeps Wnt/β-catenin signals in check. Loss
of cadherin-mediated cell adhesion can promote β-catenin
signaling. The E-cadherin/β-catenin complex is very impor-
tant in maintaining epithelial morphology, and high-aﬃnity
E-cadherin/β-catenin interaction can be disrupted during
oncogenesis and ﬁbrosis. This complex is dysregulated in
response to mediators of inﬂammation, including MMPs,
growth factors, and cytokines, suggesting that dysregulation
of E-cadherin/β-catenin association holds promise as a new
target for therapy of ﬁbrotic disorders and cancer.
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